Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.
Gossec L, Le Henanff A, Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Alexandre C, Dougados M.
Gossec L, et al. Among authors: claudepierre p.
Rheumatology (Oxford). 2006 Jul;45(7):859-62. doi: 10.1093/rheumatology/kel015. Epub 2006 Jan 25.
Rheumatology (Oxford). 2006.
PMID: 16436489
Clinical Trial.